Memo: GC & CT screening / Alternate diabetes screening / COVID-19 documentation & data collection

The purpose of this memo is to share information with perinatal care providers about some key changes to usual screening processes that have evolved out of the response to COVID-19. In addition, RCP is collecting data related to COVID-19 infections in pregnancy and in newborns, and are providing guidance about locations for documenting this information so that it can be coded by our health information colleagues.

Information in this memo has been developed through input with consultants of IWK and NSHA laboratory medicine, obstetrics, and maternal fetal medicine.

Date Revised: 
April, 2020